Cancer Keys: Brain tumours and headaches

MGUS and Myeloma: What’s the link?

Latest articles: MGUS is a benign condition which does not usually require treatment. However, a small number of patients diagnosed with MGUS will go on to develop myeloma. Understanding MGUS Monoclonal gammopathy of undetermined significance (MGUS) is a benign...

read more

#hellomynameis – Tom, Senior Media Technologist

Latest articles: With communication at the heart of GatewayC and fundamental to improving patient care, this blog series focuses on introductions and reflections from the team behind the programme. In this post, we’re introducing Tom, Senior Media Technologist. Could...

read more

Welcome to Cancer Keys, a regular bite-sized learning column brought to you by GatewayC in collaboration with Cancer Research UK.

 

Brain tumours and headaches

Whilst many people may associate brain tumours with headaches, often affected patients do not present with a headache until a later stage, if at all.

Potential pitfall

Only up to 16% of brain tumour patients present to their GP with an isolated headache*; some diagnosed patients will never develop a headache. It is important to be vigilant for other progressive neurological symptoms including visual field loss, personality changes or new-onset seizures.

Helpful hint

NICE NG12 guidelines advise an urgent direct access MRI (or CT) scan within two weeks for adults with progressive, sub-acute loss of central neurological function (or a suspected cancer referral if MRI/CT unavailable), or a very urgent referral (within 48 hours) for children and young people with newly abnormal cerebellar or other central neurological function.

 

Cancer Keys are a collaboration between GatewayC and Cancer Research UK. Brain tumour patients do not present with a headache until a later stage, if at all. Access GatewayC’s Brain Tumour – Early Diagnosis course here.

*Pract, J. (2008) Imaging patients with suspected brain tumour: guidance for primary care 

Estimates of the proportion of patients with tumour who present with isolated headache range between 2% and 16%

LinkedIn Twitter Facebook